Long-Term Results from an Epiretinal Prosthesis to Restore Sight to the Blind

• Published in: Ophthalmology (Rochester, Minn.) Vol. 122; no. 8; pp. 1547 - 1554
• Main Authors: Ho, Allen C., Humayun, Mark S., Dorn, Jessy D., da Cruz, Lyndon, Dagnelie, Gislin, Handa, James, Barale, Pierre-Olivier, Sahel, José-Alain, Stanga, Paulo E., Hafezi, Farhad, Safran, Avinoam B., Salzmann, Joel, Santos, Arturo, Birch, David, Spencer, Rand, Cideciyan, Artur V., de Juan, Eugene, Duncan, Jacque L., Eliott, Dean, Fawzi, Amani, Olmos de Koo, Lisa C., Brown, Gary C., Haller, Julia A., Regillo, Carl D., Del Priore, Lucian V., Arditi, Aries, Geruschat, Duane R., Greenberg, Robert J.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.08.2015
• Subjects: Adult; Aged; Blindness - rehabilitation; Electrodes, Implanted; Female; Follow-Up Studies; Humans; Male; Microelectrodes; Middle Aged; Ophthalmology; Prospective Studies; Prosthesis Implantation; Reproducibility of Results; Retinitis Pigmentosa - physiopathology; Retinitis Pigmentosa - surgery; Single-Blind Method; Vision, Low - rehabilitation; Visual Acuity - physiology; Visual Prosthesis; FDA; VPU; logMAR; FLORA; SAE; RP; serious adverse event; Functional Low-vision Observer Rated Assessment; retinitis pigmentosa; logarithm of the minimum angle of resolution; Food and Drug Administration; video processing unit

Retinitis pigmentosa (RP) is a group of inherited retinal degenerations leading to blindness due to photoreceptor loss. Retinitis pigmentosa is a rare disease, affecting only approximately 100 000 people in the United States. There is no cure and no approved medical therapy to slow or reverse RP. Th...